Uncover key drivers, emerging technologies, and competitive movements shaping the hydrogenated hydrocarbon resin market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Atrial Fibrillation Devices Market between 2026 and 2030?

The atrial fibrillation devices market has experienced significant growth in recent years. It is projected to expand from $8.6 billion in 2025 to $9.61 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.7%. The historical growth of this market is attributable to the increasing prevalence of atrial fibrillation, a growing geriatric population, the rising burden of cardiovascular diseases, the expansion of electrophysiology labs, and the wider adoption of implantable cardiac devices.

The atrial fibrillation devices market is projected to experience swift expansion in the coming years. This market is set to reach $14.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this growth during the forecast period include progress in ablation technologies, the wider adoption of remote patient monitoring, heightened awareness regarding stroke prevention, the increasing number of ambulatory surgical centers, and innovations in mapping and navigation systems. Key trends anticipated during this period encompass the increasing acceptance of catheter ablation procedures, the expanding utilization of wearable and remote ECG monitoring devices, a growing demand for minimally invasive AFib therapies, wider deployment of left atrial appendage closure devices, and an enhanced emphasis on early diagnosis and sustained rhythm tracking.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25704&type=smp

Which Drivers Are Expected To Impact The Atrial Fibrillation Devices Market During The Forecast Period?

The escalating prevalence of cardiovascular diseases is set to boost the expansion of the atrial fibrillation device market in the coming period. Cardiovascular diseases encompass conditions affecting the heart and blood vessels, including ailments like heart attacks, strokes, and hypertension. The rise in these diseases is driven by a worldwide increase in obesity and diabetes, combined with prevalent sedentary habits and poor dietary choices. Atrial fibrillation (AFib) devices are instrumental in managing cardiovascular diseases by identifying, tracking, and treating abnormal heart rhythms, which are frequently connected to or caused by existing heart problems. As an illustration, in June 2024, data from the American Heart Association, a US-based public health organization, indicated that as high blood pressure is expected to rise from 51.2% to 61.0%, the population diagnosed with cardiovascular diseases is projected to grow from 128 million in 2020 to over 184 million by 2050. Hence, the increasing incidence of cardiovascular diseases is fueling the growth of the atrial fibrillation device market.

Which Segments Are Driving Activity In The Atrial Fibrillation Devices Market?

The atrial fibrillation devices market covered in this report is segmented –

1) By Device Type: Implantable Devices, External Devices, Catheter-Based Devices

2) By Product: Electrophysiology Ablation Catheters, Cardiac Monitors Or Implantable Loop Recorder, Electrophysiology Diagnostic Catheters, Mapping And Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, Other Products

3) By Technology: Radiofrequency, Cryotherapy, Ultrasound, Other Technologies

4) By Distribution Channel: Direct Sales, Distributors, Online Sales

5) By End-Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Implantable Devices: Implantable Cardioverter Defibrillators, Pacemakers, Insertable Cardiac Monitors

2) By External Devices: External Defibrillators, Holter Monitors, Mobile Cardiac Telemetry Devices, Electrocardiogram Monitors

3) By Catheter-Based Devices: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Mapping and Navigation Systems, Transseptal Access Devices

Which Market Trends Are Opening Growth Opportunities In The Atrial Fibrillation Devices Market?

Major companies in the atrial fibrillation devices market are increasingly focusing on technological advancements, such as patient-centric clinical decision support tools, to boost diagnostic precision, customize treatment strategies, and improve overall patient outcomes. These digital solutions assist healthcare professionals in making tailored treatment decisions by analyzing individual patient information. For example, in August 2023, US-based medical technology company GE HealthCare Technologies Inc. unveiled CardioVisio for Atrial Fibrillation, a digital clinical decision support tool engineered to optimize clinician workflows and facilitate precision care for individuals with atrial fibrillation. This tool allows healthcare providers to observe the progression of AFib, including past diagnoses, treatments, medications, and associated conditions. The platform offers therapy recommendations based on guidelines, helping to reduce diagnostic errors and streamline clinical decision-making. CardioVisio organizes fragmented patient data into an accessible format, reducing the burden on medical staff and enabling more timely, personalized, and effective management of atrial fibrillation.

Which Key Market Players Are Investing In Expansion And Innovation Within The Atrial Fibrillation Devices Market?

Major companies operating in the atrial fibrillation devices market are Johnson And Johnson Services Inc, Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips NV, Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co Ltd, Japan Lifeline Co Ltd, AliveCor Inc, CardioFocus Inc, Imricor Medical Systems Inc, Kardium Inc, Stereotaxis Inc, Volta Medical, Osypka AG, CathRx Ltd, BIOTRONIK SE And Co KG, EP Solutions SA, CardiacSense Ltd, Biosense Webster Inc, Abbott Electrophysiology, Medtronic Cardiac Rhythm And Heart Failure, Boston Scientific Electrophysiology

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-devices-global-market-report

Which Regions Are Poised For Strategic Growth In The Atrial Fibrillation Devices Market?

North America was the largest region in the atrial fibrillation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial fibrillation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Atrial Fibrillation Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25704&type=smp

Browse Through More Reports Similar to the Global Atrial Fibrillation Devices Market 2026, By The Business Research Company

Cardiac Arrhythmia Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Ventricular Fibrillation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ventricular-fibrillation-global-market-report

Cardiovascular Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company